Replies to post #484589 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

If a study’s sponsor is required by law to release certain information before time of publication, it should do only the minimum required and not name NEJM.

If substantial publicity for a study occurs before or during the peer-review process, priority for publication could be affected. The more said in a press release prior to publication, the greater the negative impact may be on priority for publication.

[Troymister]

I essentially asked that question in an email to investor relations three days ago. Still no response...just the automatic reply saying, "Thank you...we'll get back to you soon."

I must acknowledge that NWBO's definition of "soon" has always been substantially different from mine.